The AI in drug discovery market size was valued at USD 1.99 billion in 2024. The market is projected to grow from USD 2.65 billion in 2025 to USD 35.42 billion by 2034, exhibiting a CAGR of 29.6% during 2025–2034. This extraordinary growth trajectory reflects a fundamental reconfiguration of pharmaceutical R&D, where artificial intelligence is no longer experimental but instrumental...

"Executive Summary Alzheimer's Therapeutics Market Size and Share: Global Industry Snapshot During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.36%, primarily driven by the increasing prevalence of Alzheimer's disease For an actionable market insight and lucrative business strategies, a faultless market research report has to be there....

“According to a new report published by Introspective Market Research, Animal Model Market by Type, Application, and End User, The Global Animal Model Market Size Was Valued at USD 2.87 Billion in 2023 and is Projected to Reach USD 4.11 Billion by 2032, Growing at a CAGR of 8.6% from 2024 to 2032.” The Animal Model Market plays a critical role in biomedical research, pharmaceutical...

AI in Antithrombotic Drug Development: Transforming the Future of the Antithrombotic Drugs Market The integration of artificial intelligence (AI) into pharmaceutical research is revolutionizing modern medicine, particularly in cardiovascular therapeutics. One of the most promising areas of impact is antithrombotic therapy, where AI is accelerating discovery, improving drug safety, and...

"Executive Summary Apoptosis Assays Market Research: Share and Size Intelligence CAGR Value Data Bridge Market Research analyses that the apoptosis assays market which was USD 3315.7 million in 2021, is expected to reach USD 6558.41 million by 2029, at a CAGR of 8.9% during the forecast period 2022 to 2029. Apoptosis Assays Market report makes available the valuable information...

The Asia Pacific Gaucher Disease Treatment Market is projected to reach a valuation of USD 553.77 million by 2034, growing at a compound annual growth rate (CAGR) of 3.2% over the forecast period (2024–2034). The growth of this market is driven by increasing rare disease awareness, improved healthcare infrastructure, expanding newborn screening programs, and the...

Executive Summary Asia-Pacific Automated Cell Cultures Market : CAGR Value Asia-Pacific automated cell cultures market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.8% in the forecast period of 2022 to 2029 and is expected to reach EURO 5,624.00 million by 2029. This...

"Executive Summary Asia-Pacific Calcineurin Inhibitors Market Size, Share, and Competitive Landscape Asia-Pacific calcineurin inhibitors market size was valued at USD 1.64 billion in 2024 and is projected to reach USD 4.03 billion by 2032, with a CAGR of 11.9% during the forecast period of 2025 to 2032. To attain knowhow of market landscape, brand awareness, latest trends, possible future...

The autoimmune drugs market is witnessing consistent expansion due to a growing global patient pool and advancements in immunology research. Autoimmune diseases occur when the immune system mistakenly attacks healthy cells, requiring long-term therapeutic management. Increasing awareness, improved diagnostic capabilities, and advancements in biologics and targeted therapies are fueling market...

Market Overview The global Autonomous Emergency Braking (AEB) system market is witnessing rapid growth as automakers, regulators, and consumers prioritize road safety, collision prevention, and intelligent mobility. Valued at USD 42.58 billion in 2024, the market is projected to reach USD 226.65 billion by 2032, expanding at a CAGR of 23.20%. AEB...